Acurx Pharmaceuticals (ACXP) Institutional Ownership $0.47 -0.03 (-5.21%) Closing price 07/11/2025 03:59 PM EasternExtended Trading$0.47 0.00 (-0.85%) As of 07/11/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Acurx Pharmaceuticals (NASDAQ:ACXP)CurrentInstitutional OwnershipPercentage11.53%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$144.01KNumber ofInstitutional Sellers(last 12 months)0 Get ACXP Insider Trade Alerts Want to know when executives and insiders are buying or selling Acurx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ACXP Institutional Buying and Selling by Quarter Acurx Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/11/2025Vanguard Capital Wealth Advisors67,500$26K0.0%N/A0.301% 4/11/2025Prospect Financial Services LLC366,576$143K0.1%+11.4%1.637% 1/22/2025Prospect Financial Services LLC329,076$268K0.1%+11.5%1.932% 11/16/2024Geode Capital Management LLC146,500$278K0.0%+12.7%0.902% 10/15/2024Prospect Financial Services LLC295,075$561K0.3%+6.1%1.862% 7/15/2024Prospect Financial Services LLC278,100$626K0.5%+1.9%1.756% 4/23/2024Prospect Financial Services LLC272,850$668K0.6%+6.9%1.732% 4/5/2024 NBC Securities Inc.14,000$34K0.0%N/A0.089% 2/20/2024Prospect Financial Services LLC255,150$977K1.0%N/A1.853% 2/1/2024Sigma Planning Corp10,000$38K0.0%N/A0.073% 11/15/2023Armistice Capital LLC500,000$750K0.0%-57.7%3.843% 8/14/2023One68 Global Capital LLC13,044$35K0.2%N/A0.101% 11/14/2022Armistice Capital LLC1,066,000$3.20M0.1%N/A9.224% 8/12/2022Semmax Financial Advisors Inc.5,879$28K0.0%+365.5%0.057% 8/1/2022Castle Wealth Management LLC13,000$49K0.0%N/A0.127% 1/10/2022Patriot Financial Group Insurance Agency LLC7,000$30K0.0%+75.0%0.069% 11/15/2021Tocqueville Asset Management L.P.19,100$98K0.0%+91.0%0.189% 11/9/2021BlackRock Inc.6,515$33K0.0%N/A0.064% 8/16/2021Tocqueville Asset Management L.P.10,000$64K0.0%N/A0.105% (Data available from 1/1/2016 forward) ACXP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ACXP shares? During the previous two years, the following institutional investors and hedge funds held shares of Acurx Pharmaceuticals shares: Armistice Capital LLC ($750K), Geode Capital Management LLC ($278K), Prospect Financial Services LLC ($143K), Sigma Planning Corp ($38K), One68 Global Capital LLC ($35K), and NBC Securities Inc. ($34K), and Vanguard Capital Wealth Advisors ($26K).Learn more on Acurx Pharmaceuticals' institutional investors. What percentage of Acurx Pharmaceuticals' stock is owned by institutional investors? 11.53% of Acurx Pharmaceuticals' stock is owned by institutional investors. Learn more on ACXP's institutional investor holdings. Which institutional investors have been buying Acurx Pharmaceuticals' stock? The following institutional investors have purchased Acurx Pharmaceuticals' stock in the last 24 months: Prospect Financial Services LLC ($366.58K), Vanguard Capital Wealth Advisors ($67.50K), Geode Capital Management LLC ($16.49K), NBC Securities Inc. ($14K), One68 Global Capital LLC ($13.04K), and Sigma Planning Corp ($10K). How much institutional buying is happening at Acurx Pharmaceuticals? Institutional investors have bought a total of 177,711 shares in the last 24 months. This purchase volume represents approximately $144.01K in transactions. Related Companies Pluri Major Shareholders Prelude Therapeutics Major Shareholders Mural Oncology Major Shareholders Actinium Pharmaceuticals Major Shareholders Scilex Major Shareholders Grace Therapeutics Major Shareholders Exicure Major Shareholders Acrivon Therapeutics Major Shareholders PepGen Major Shareholders Shattuck Labs Major Shareholders This page (NASDAQ:ACXP) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acurx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acurx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.